| 1. |
- Jonsson, Thomas Björn, 1971-, et al.
(författare)
-
Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia
- 2014
-
Ingår i: European Journal of Clinical Pharmacology. - : Springer. - 0031-6970 .- 1432-1041. ; 70:8, s. 957-963
-
Tidskriftsartikel (refereegranskat)abstract
- Patients suffering from critical limb ischemia (CLI) have poor wound healing in the ankle and foot areas. Secondary wound infections are frequent and often treated with prolonged courses of antibiotics.This study set out to investigate to what extent the unbound fraction of 4 g of cloxacillin i.v. reaches its target organ in poorly vascularized tissues, i.e., the calf and foot of patients suffering from CLI.Cloxacillin concentrations were measured by HPLC in serum and in microdialysis samples from skin and muscle of the lower part of the calf and as reference subcutaneously at the pectoral level in eight patients suffering from CLI (four males, four females, mean age 78 years, range 66-85 years) and in three healthy controls (two females, one male, mean age 67, range 66-68 years).In patients suffering from CLI, the tissue penetration of cloxacillin after a single 4 g dose was comparable to that of healthy controls, despite impaired blood circulation.The reduced blood flow in the peripheral vessels of the CLI patients presented here apparently is not the rate-limiting factor for delivery or tissue penetration of cloxacillin.
|
|
| 2. |
- Breimer, Lars H, et al.
(författare)
-
A longitudinal and cross-sectional study of Swedish biomedical PhD processes 1991-2009 with emphasis on international and gender aspects
- 2010
-
Ingår i: Scientometrics. - : Springer Netherlands. - 0138-9130 .- 1588-2861. ; 85:2, s. 401-414
-
Tidskriftsartikel (refereegranskat)abstract
- This longitudinal survey of Swedish biomedical PhDs from 1991 to 2009 found a 2.5-fold increase in biomedical PhD graduates, especially women, and mainly non-MDs, while the number of MDs remained fairly constant. The proportion obtaining a biomedical PhD in Sweden in 2006 was two and a half times that in USA compared to population and three and a half times by GDP, but similar to that of the Netherlands. Female non-MD but not female MD candidates were more likely than men to be examined by female examiners. Fewer of the non-MD than MD women continued to publish in English after their PhD. The median number of authors per paper in a thesis had increased by 1 (from 4 to 5) compared with 15–20 years ago. Swedish biomedical research was already well internationalized in 1991, when 38% of the external examiners came from abroad. This rose to 53% in 2003 but in 2009 had returned to 42%. USA and UK were the most common countries but Australia accounted for 2%. When assessed by connection with foreign research teams, Swedish researchers were also internationally well connected. Studies in other countries are needed to assess how generally applicable these findings are. Our findings suggest that the policy and management of Swedish scientific research systems needs revision to harmonize with the national economic capacity.
|
|
| 3. |
- Breimer, Lars H., et al.
(författare)
-
Considerations for appointing an external examiner of a PhD in the biomedical sciences in Sweden : a questionnaire-based survey
- 2014
-
Ingår i: Scientometrics. - : Springer. - 0138-9130 .- 1588-2861. ; 98:3, s. 2039-2049
-
Tidskriftsartikel (refereegranskat)abstract
- A survey of 170 Swedish mentors of PhD-students found that expertise in the research field and avoidance of conflict of interest were big motivators for finding an examiner from abroad for PhD theses. The survey also identified that concern by supervisors for facilitating the career paths of younger scientists in terms of introductions to potential labs for post-doctoral work and obtaining high quality neutral review of one's research was also important, as was the desire to set up collaborations. An expectation from the management of one's university of the PR-value of a foreign senior person as examiner also played a part. Although few were willing to admit that PR for one's own group was a motivating factor. A small fraction of responders expressed concern that, as some of the costs of the PhD-examination were being shifted on to the research groups themselves, this might impact the current situation. Language also played a subordinate role. To get the best out of the visiting examiner, it was important to educate and instruct them in their role in a Swedish PhD-examination protocol. Male supervisors had had more PhD-candidates than female, but they also had used more Sweden-based examiners than their female colleagues. We conclude that using a foreign examiner was motivated by factors that are likely to prevail for the foreseeable future. This Swedish practice may also provide a template for a common standard.
|
|
| 4. |
- Breimer, Lars H., et al.
(författare)
-
Ethical stumbling blocks in uncovering folate deficiency as a preventable cause of spina bifida
- 2017
-
Ingår i: Indian journal of medical ethics. - : Forum for Medical Ethics Society. - 0975-5691. ; 2:4, s. 260-265
-
Tidskriftsartikel (refereegranskat)abstract
- The year 2016 witnessed the anniversaries of several key events related to the prevention of neural tube defects (NTD) with folate supplementation. However, the road leading up to this achievement was full of stumbling blocks, both in terms of research ethics and researcher ethics. First, the decisions of ethics review boards differed with respect to allowing placebo groups in folate trials, thus reducing the level of evidence obtained from the earliest studies. Second, statisticians insisted on analysing the outcome of a trial by intention-to-treat - which turned out to be non-significant - rather than by treatment received, which was statistically significant. Third, the recognition of positive results was stymied by the reluctance of some researchers to recognise and quote others' contributions. All this needlessly delayed the recognition of the NTD-preventive effects of folate by a decade. The story of the prevention of NTD thus offers insights into research inadequacies that have the potential to impede the advance of medical science, with the ethical aspects having the most immediate impact. Efficient ethics review boards play a major role worldwide and if they play safe, they may risk disallowing high-quality studies of great public health import.
|
|
| 5. |
- Breimer, Lars H., et al.
(författare)
-
Has folate a role in the developing nervous system after birth and not just during embryogenesis and gestation?
- 2012
-
Ingår i: Scandinavian Journal of Clinical and Laboratory Investigation. - London, United Kingdom : Informa Healthcare. - 0036-5513 .- 1502-7686. ; 72:3, s. 185-191
-
Forskningsöversikt (refereegranskat)abstract
- It is now 30 years since the first publications stating that supplementation with folate could prevent neural tube defects appeared and 20 years since the definitive data, including prevention of other birth defects. Since then epidemiological studies and animal experiments have identified folate as a molecule at the crossroads of neural development. Fortification of food has greatly reduced the incidence of spina bifida. Much interest has focussed on long-term sequelae in children born to mothers severely deprived of folate (and other nutrients) such as during the Dutch Hunger Winter of 1944 and in poor parts of the world. In addition, deficiency in folate and B12 are increasingly discussed as a possible contributing factor in dementia and congenital orofacial and heart malformations. The year 2011 saw the publication of a study that implicated low folate intake in poorer school performance of adolescents as judged by school marks. This has enormous social implications but needs confirmation from other settings. This review assesses the current state of evidence and sets the data in context of whether folate has a role in the development and plasticity of the nervous system even after birth, with particular emphasis on childhood and adolescence.
|
|
| 6. |
- Breimer, Lars H., et al.
(författare)
-
Immune checkpoint inhibitors of the PD-1/PD-L1-axis in non-small cell lung cancer : promise, controversies and ambiguities in the novel treatment paradigm
- 2020
-
Ingår i: Scandinavian Journal of Clinical and Laboratory Investigation. - : Taylor & Francis. - 0036-5513 .- 1502-7686. ; 80:5, s. 360-369
-
Forskningsöversikt (refereegranskat)abstract
- Immune checkpoint inhibitors (ICIs) have received much attention not least for melanoma since the award of the Nobel prize in 2018. Here, we review the current state of knowledge about the use of these monoclonal antibodies (mAbs) in non-small cell lung cancer (NSCLC). These drugs have generally been conditionally approved on limited early data and there are few long-term follow-up data from randomized clinical trials. The effect observed for NSCLC thus far is, on average, moderately better than that obtained with chemotherapy. Severe side-effects are more common than might have been expected. The drugs themselves are expensive and are associated with time-consuming histopathologic testing even though the predictive value of these tests can be discussed. In addition, monitoring for side-effects involves increased workload and budgetary expense for clinical chemistry laboratories. Here, we review and summarize the current knowledge, controversies and ambiguities of ICIs for the treatment of NSCLC.
|
|
| 7. |
|
|
| 8. |
- Breimer, Lars H., et al.
(författare)
-
Morgondagens laboratorium - redan i går
- 2012
-
Ingår i: Läkartidningen. - Stockholm : Sveriges läkarförbund. - 0023-7205 .- 1652-7518. ; 109:37, s. 1624-1624
-
Tidskriftsartikel (refereegranskat)
|
|
| 9. |
|
|
| 10. |
|
|
